MedTrace Logo

Comparison of Clinical Performance of Two Monthly Replacement Toric Soft Contact Lenses

NCT06165627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2025-05-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the clinical performance of TOTAL30 for Astigmatism (T30fA) soft contact lenses with Biofinity Toric soft contact lenses.

Conditions

  • Ametropia
  • Astigmatism

Interventions

DEVICE

Lehfilcon A toric contact lenses

Commercially available soft contact lenses worn as indicated

DEVICE

Comfilcon A toric contact lenses

Commercially available soft contact lenses) worn as indicated

DEVICE

CLEAR CARE

Commercially available hydrogen peroxide-based solution for daily cleaning and disinfection of contact lenses used as indicated

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Lead, Vision Care · Alcon Research, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-23
Primary Completion
2024-05-12
Completion
2024-05-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06165627 on ClinicalTrials.gov